scispace - formally typeset
N

Natascha Schaefer

Researcher at University of Würzburg

Publications -  32
Citations -  663

Natascha Schaefer is an academic researcher from University of Würzburg. The author has contributed to research in topics: Glycine receptor & Hyperekplexia. The author has an hindex of 11, co-authored 27 publications receiving 435 citations. Previous affiliations of Natascha Schaefer include University of Erlangen-Nuremberg.

Papers
More filters
Journal ArticleDOI

A versatile biomaterial ink platform for the melt electrowriting of chemically-crosslinked hydrogels

TL;DR: An advanced material platform based on PEtOzi is reported that is compatible with MEW and results in functionalizable chemically crosslinked microperiodic hydrogels that are compatible with confocal imaging and staining protocols for cells.
Journal ArticleDOI

GLRB allelic variation associated with agoraphobic cognitions, increased startle response and fear network activation: a potential neurogenetic pathway to panic disorder

TL;DR: The genome-wide association study with a dimensional, PD/AG-related anxiety phenotype based on the Agoraphobia Cognition Questionnaire provides evidence that non-coding, although functional GLRB gene polymorphisms may predispose to PD by increasing startle response and agoraphobic cognitions.
Journal ArticleDOI

The malleable brain: plasticity of neural circuits and behavior – a review from students to students

Natascha Schaefer, +33 more
TL;DR: A review of the role of plasticity during development and the persistent changes of neural circuitry occurring when sensory input is altered during critical developmental stages, and the signaling cascades resulting in the synthesis of new plasticity‐related proteins, which ultimately enable sustained changes in synaptic strength.
Journal ArticleDOI

Glycine receptor mouse mutants: model systems for human hyperekplexia.

TL;DR: A novel route that uses gene‐therapeutic modulation of mutated receptors to overcome loss of function mutations is described and described, which is possible to associate behavioural changes with pharmacological differences in glycinergic inhibition.